| Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study S Siragusa, A Malato, G Saccullo, A Iorio, M Di Ianni, C Caracciolo, ... American journal of hematology 86 (11), 914-917, 2011 | 75 | 2011 |
| Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice C Fava, G Rege-Cambrin, I Dogliotti, M Cerrano, P Berchialla, M Dragani, ... haematologica 104 (8), 1589, 2019 | 73 | 2019 |
| Immunosenescence and lymphomagenesis S Mancuso, M Carlisi, M Santoro, M Napolitano, S Raso, S Siragusa Immunity & Ageing 15, 1-7, 2018 | 46 | 2018 |
| The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep V Accurso, M Santoro, S Mancuso, M Napolitano, M Carlisi, M Mattana, ... Clinical Medicine Insights: Blood Disorders 13, 2634853520978210, 2020 | 40 | 2020 |
| Cancer patients requiring interruption of long‐term warfarin because of surgery or chemotherapy induced thrombocytopenia: The use of fixed sub‐therapeutic doses of low … G Saccullo, A Malato, S Raso, M Santoro, V Zammit, A Casuccio, ... American journal of hematology 87 (4), 388-391, 2012 | 37 | 2012 |
| Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review A Malato, G Saccullo, LL Coco, S Mancuso, M Santoro, S Martino, ... Blood Transfusion 10 (4), 428, 2012 | 33 | 2012 |
| Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study V Accurso, M Santoro, S Raso, AD Contrino, P Casimiro, FD Piazza, ... Hematology Reports 11 (4), 8281, 2019 | 28 | 2019 |
| Cardiovascular issues in tyrosine kinase inhibitors treatments for chronic myeloid leukemia: a review M Santoro, S Mancuso, V Accurso, D Di Lisi, G Novo, S Siragusa Frontiers in Physiology 12, 675811, 2021 | 22 | 2021 |
| Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk … S Mancuso, M Santoro, V Accurso, G Agliastro, S Raso, F Di Piazza, ... Oncology Research and Treatment 43 (10), 526-530, 2020 | 21 | 2020 |
| A multicenter real-life study on anticoagulant treatment with direct oral anticoagulants in patients with Ph-negative myeloproliferative neoplasms A Serrao, M Breccia, M Napolitano, L Fiori, M Santoro, E Scalzulli, ... American journal of hematology 95 (12), E329-E332, 2020 | 19 | 2020 |
| Cardiovascular risk in essential thrombocythemia and polycythemia vera: thrombotic risk and survival V Accurso, M Santoro, S Mancuso, AD Contrino, P Casimiro, M Sardo, ... Mediterranean Journal of Hematology and Infectious Diseases 12 (1), 2020 | 18 | 2020 |
| The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity D Di Lisi, C Madaudo, G Alagna, M Santoro, L Rossetto, S Siragusa, ... ESC Heart Failure 9 (3), 1914-1919, 2022 | 17 | 2022 |
| Bone damage after chemotherapy for lymphoma: a real-world experience S Mancuso, D Scaturro, M Santoro, G Di Gaetano, F Vitagliani, V Falco, ... BMC Musculoskeletal Disorders 22, 1-9, 2021 | 14 | 2021 |
| Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors SS Santoro M, Accurso V, Mancuso S, Contrino AD, Sardo M, Novo G, Di Piazza ... Chemotherapy 11, 1-5, 2019 | 11* | 2019 |
| Host‐related factors and cancer: Malnutrition and non‐Hodgkin lymphoma S Mancuso, M Mattana, M Santoro, M Carlisi, S Buscemi, S Siragusa Hematological Oncology 40 (3), 320-331, 2022 | 10 | 2022 |
| Comparison between thrombotic risk scores in essential thrombocythemia and survival implications M Santoro, V Accurso, S Mancuso, M Carlisi, S Raso, G Tarantino, ... Hematological oncology 37 (4), 434-437, 2019 | 10 | 2019 |
| Paroxysmal nocturnal hemoglobinuria: When delay in diagnosis and long therapy occurs S Mancuso, G Sucato, M Carlisi, M Santoro, G Tarantino, E Iannitto, ... Hematology Reports 10 (1), 7523, 2018 | 10 | 2018 |
| Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy S Mancuso, M Mattana, M Carlisi, M Santoro, S Siragusa International Journal of Molecular Sciences 23 (6), 3368, 2022 | 9 | 2022 |
| Observational study of CML Italian patients who discontinued TKIs C Fava, G Rege-Carmbrin, I Dogliotti, M Cerrano, P Berchialla, G Rosti, ... Blood 130, 1616, 2017 | 9 | 2017 |
| P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PROFILE IN HEAVILY PRE-TREATED CML PATIENTS M Breccia, AVR Rossi, B Martino, E Abruzzese, M Annunziata, G Binotto, ... HemaSphere 6, 607-608, 2022 | 8 | 2022 |
prof. sergio siragusaFull Professor of Hematology, University of Palermo, italyVerified email at unipa.it
